Award

Role of Autophagy and Beclin1 in Direct Cardiac Reprogramming

Description: Heart disease leads to worldwide adult and childhood mortality, largely due to the loss of cardiomyocytes that are difficult to be salvaged. Since adult cardiomyocytes have limited regenerative potential upon injury, development of approaches for cardiac regeneration is an urgent issue. Direct conversion of cardiac fibroblasts (CFs) into induced cardiomyocytes (iCMs) holds great promise as a novel therapy for treatment of heart failure. Three transcriptional factors, Gata4, Mef2c and Tbx5 (G,M,T) are sufficient to transdifferentiate CFs to iCMs both in vitro and in vivo. However, the mechanism that regulates this process is largely unknown. Recently, we found that re-establishment of chromatin and epigenetic structures as well as removal of existing fibroblast signatures lay foundation of successful cell fate conversion. In another effort to characterize the molecular mechanism of this cellular renovation, we surprisingly found that autophagy, an evolutionally conserved self-digestion process, is activated during reprogramming. Boosting autophagy significantly enhanced iCM production. Autophagy requires the core components for initiation and elongation, including a core regulator called Beclin1. I discovered that knocking down Beclin1 leads to an increased number of iCMs with improved quality, followed with attenuated autophagy response. I hypothesize that Beclin1 regulates iCM reprogramming potentially through autophagy dependent and independent pathways. To test this hypothesis, I will further define the dynamics of autophagy and discern the contribution of each reprogramming factor or factor combinations for autophagy activation. Role of Beclin1 in reprogramming will be further characterized by a series of biochemical and molecular assays. Taking advantages of our well-established platform for in vivo reprogramming, I will further determine the function of Beclin1 using becnlin1 genetically deficient mice. Taken together, my project will focus on the role of Beclin1 regulated autophagic program during both in vivo and in vitro cardiac reprogramming. My findings will further our understanding on reprogramming process and provide the scientific foundation to move direct reprogramming closer to practical application for the treatment of prevalent and morbid heart diseases.
Amount: $231,000
Funding type: fellowship
Funder scheme: Career Development Award
Start date: 2018-07-01
End date: 2020-09-05
Investigator: Li Wang (lead)
Institutions: University of North Carolina at Chapel Hill, The University of North Carolina at Chapel Hill
Funded outputs count: 4
Funder award ID: 18CDA34110340
OpenAlex ID: G6628600110
2021 · Li Wang, Yuchen Yang, et al. · Cardiovascular Research · 78
2020 · Li Wang, Hong Ma, et al. · Science Translational Medicine · 72
2020 · Li Wang, Peisen Huang, et al. · Cells · 17